Biocon posts growth of 64% in net profit at Rs 213.7 cr during Q4

Strong performance owing to growth in biologics, research services and small molecules business, says company

Biopharmaceutical firm Biocon Ltd on Thursday posted a growth of 64 per cent in net profit at Rs 213.7 crore during the quarter ended March 31, 2019, as compared to Rs 130.4 crore during the same period last year. Its research services subsidiary Syngene reached a milestone of Rs 100 crore in net profit during the quarter on a standalone basis.

Total revenue during the quarter grew by 26 per cent to Rs 1557 crore compared to Rs 1237 crore during the same quarter last year. The performance was led by the growth in biologics and research services, supported by